Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2003
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199673 For inducing immune response and administering immunotherapy
10/23/2003US20030199582 Tolterodine salts
10/23/2003US20030199575 P-hydroxyphenyl propionic acid derivatives as antiproliferative agents
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199548 Administering quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives containing one of the ring selected from benzene, pyridine, thienyl, furanyl, imidazolyl and triazolyl for therapy in pain management
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003US20030199538 Imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines and other amines containing heterocyclic rings, a fatty acid and a hydrophobic, aprotic component miscible with fatty acid; useful for skin disorders
10/23/2003US20030199537 Macrocyclic lactone useful in immunosuppressant therapy
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199502 Indoloquinazolinones
10/23/2003US20030199491 Quinoline derivatives having vegf inhibiting activity
10/23/2003US20030199485 Novel anti-inflammatory androstane derivative
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199473 For therapy of retrovirus infection
10/23/2003US20030199466 For modulating an immune response
10/23/2003US20030199461 3-beta-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof
10/23/2003US20030199456 Sodium channel blockers
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198697 Administering plant extracts; health food
10/23/2003US20030198643 Adjuvant enhanced immunotherapy
10/23/2003US20030198642 Vaccine vehicle; induce immunology response; anticancer agents
10/23/2003US20030198636 Prevent completitive binding; amplification inflammation response; convertase inhibitor; side effect reduction
10/23/2003US20030198623 Attenuation Dna; coding cytokines, tumor antigen
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198601 Dry powder drug; aerosol administering
10/23/2003CA2484261A1 Piperidine derivatives having ccr3 antagonism
10/23/2003CA2482926A1 Modified factor viii
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482775A1 Fredericamycin derivatives
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482713A1 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481855A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003CA2481752A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481669A1 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481462A1 Heteroclitic analogs and related methods
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2481184A1 Medicament for preventing and/or treating chronic rejection
10/23/2003CA2481178A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003CA2481042A1 Mycoplasma polypeptides
10/23/2003CA2480879A1 Tyrosine kinase inhibitors
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2478392A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003CA2477692A1 Cyanamides useful as reversible inhibitors of cysteine proteases
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354950A1 Nf-kb activating gene
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1354882A1 Dipeptidyl peptidase iv inhibitor
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1354877A1 Hetero-tricyclic compounds having substituted amino groups
10/22/2003EP1354603A1 Concomitant drugs
10/22/2003EP1354601A1 Transplantation rejection inhibitors
10/22/2003EP1354599A2 Pharmaceutical or food composition for treating pathologies related to graft versus host
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354596A1 Medicinal solution containing a quail egg extract and a solution of medicinal plant extracts
10/22/2003EP1354595A1 Composition containing extracts of butyrospermum parkii and its use as medicament or dietary supplement
10/22/2003EP1354582A2 Emulsion preconcentrates containing cyclosporin or a macrolide
10/22/2003EP1354054A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1353955A2 High affinity antibodies
10/22/2003EP1353953A2 Mu-1, member of the cytokine receptor family
10/22/2003EP1353927A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353702A2 Genetic engineering of vascular grafts to resist disease
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353691A2 Molecular antigen array presenting amyloid beta
1 ... 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 ... 1172